» Authors » Mojtaba Didehdar

Mojtaba Didehdar

Explore the profile of Mojtaba Didehdar including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 263
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Shariati A, Didehdar M, Razavi S, Heidary M, Soroush F, Chegini Z
Front Pharmacol . 2022 Jul; 13:917787. PMID: 35899117
The biofilm communities of are resistant to various antifungal treatments. The ability of to form biofilms on abiotic and biotic surfaces is considered one of the most important virulence factors...
12.
Didehdar M, Chegini Z, Tabaeian S, Razavi S, Shariati A
Front Cell Infect Microbiol . 2022 Jul; 12:930624. PMID: 35899044
Due to the potent antibacterial properties of and its derivatives, particularly cinnamaldehyde, recent studies have used these compounds to inhibit the growth of the most prevalent bacterial and fungal biofilms....
13.
Chegini Z, Didehdar M, Khoshbayan A, Karami J, Yousefimashouf M, Shariati A
Cell Commun Signal . 2022 Mar; 20(1):29. PMID: 35264183
CRS with nasal polyps (CRSwNP) is a multifactorial disease, and various etiological factors like bacterial superantigens are known to develop this disease. Recent studies reported that Staphylococcus aureus nasal colonization...
14.
Rahimpour A, Pourmaleki E, Shams F, Payandeh Z, Pourzardosht N, Didehdar M, et al.
Mol Biol Rep . 2022 Jan; 49(5):3461-3468. PMID: 35076847
Background: The increasing need for therapeutic monoclonal antibodies (mAbs) entails the development of innovative and improved expression strategies. Chromatin insulators have been utilized for the enhancement of the heterologous proteins...
15.
Faramarzi S, Motamedi M, Rezaei-Matehkolaei A, Aboutalebian S, Ansari S, Didehdar M, et al.
Curr Med Mycol . 2022 Jan; 7(2):1-7. PMID: 35028478
Background And Purpose: The most common etiological agents of human dermatophytosis in various parts of the world are , , and . The main aim of this study was to...
16.
Didehdar M, Chegini Z, Moradabadi A, Anoushirvani A, Tabaeian S, Yousefimashouf M, et al.
Microb Pathog . 2022 Jan; 163:105388. PMID: 34995749
Background: GI mucormycosis (GI) is a rare but highly lethal infection in patients. There is no single comprehensive review of the literature that demonstrates the various clinical aspects of this...
17.
Amini S, Karami Matin B, Didehdar M, Alimohammadi A, Salimi Y, Amiresmaili M, et al.
Front Public Health . 2021 Dec; 9:727669. PMID: 34900889
Aging, chronic diseases, and development of expensive and advanced technologies has increased hospitals costs which have necessitated their efficiency in utilization of resources. This systematic review and meta-analysis study has...
18.
Akbari M, Didehdar M, Nazari M, Azadi D
Future Virol . 2021 Dec; PMID: 34858514
We report two cases of pediatric patients diagnosed and treated for pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS) symptoms. Two previously healthy 3- and 4-year-old boys were referred...
19.
Shariati A, Vesal S, Khoshbayan A, Goudarzi P, Darban-Sarokhalil D, Razavi S, et al.
J Appl Microbiol . 2021 Dec; 132(4):2531-2546. PMID: 34856045
An important role has been recently reported for bacterial biofilm in the pathophysiology of chronic diseases, such as chronic rhinosinusitis (CRS). CRS, affecting sinonasal mucosa, is a persistent inflammatory condition...
20.
Tabatabaie M, Sarrami A, Didehdar M, Tasorian B, Shafaat O, Sotoudeh H
Cureus . 2021 Nov; 13(10):e18768. PMID: 34804648
Aim This study aimed to develop a predictive model to predict patients' mortality with coronavirus disease 2019 (COVID-19) from the basic medical data on the first day of admission. Methods...